Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RUCAPARIB CAMSYLATE Cause Ill-defined disorder? 9 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Ill-defined disorder have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 0.1% of all adverse event reports for RUCAPARIB CAMSYLATE.

9
Reports of Ill-defined disorder with RUCAPARIB CAMSYLATE
0.1%
of all RUCAPARIB CAMSYLATE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Ill-defined disorder From RUCAPARIB CAMSYLATE?

Of the 9 reports, 3 (33.3%) required hospitalization.

Is Ill-defined disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?

Fatigue (2,494) Nausea (2,219) Malignant neoplasm progression (1,162) Decreased appetite (787) Constipation (763) Diarrhoea (759) Vomiting (759) Asthenia (660) Adverse event (571) Carbohydrate antigen 125 increased (562)

What Other Drugs Cause Ill-defined disorder?

ACETAMINOPHEN\OXYCODONE (9,780) ACETAMINOPHEN\HYDROCODONE (6,159) TOCILIZUMAB (4,411) RITUXIMAB (4,220) ETANERCEPT (4,202) METHOTREXATE (4,063) ABATACEPT (3,630) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (3,600) LEFLUNOMIDE (3,570) CERTOLIZUMAB PEGOL (3,273)

Which RUCAPARIB CAMSYLATE Alternatives Have Lower Ill-defined disorder Risk?

RUCAPARIB CAMSYLATE vs RUFINAMIDE RUCAPARIB CAMSYLATE vs RUPATADINE RUCAPARIB CAMSYLATE vs RUXOLITINIB RUCAPARIB CAMSYLATE vs SABRIL RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE

Related Pages

RUCAPARIB CAMSYLATE Full Profile All Ill-defined disorder Reports All Drugs Causing Ill-defined disorder RUCAPARIB CAMSYLATE Demographics